DESTINY-Breast07
DESTINY-Breast07: Trastuzumab Deruxtecan ± Pertuzumab for Previously Untreated HER2+ Metastatic Breast Cancer

Released: June 04, 2024

Expiration: June 03, 2025

Activity

Progress
1
Course Completed